Brain metastases: biology and the role of the brain microenvironment
- PMID: 11595114
- DOI: 10.1007/s11912-001-0067-7
Brain metastases: biology and the role of the brain microenvironment
Abstract
Metastatic lesions constitute the most frequently occurring malignancy in the brain, and their detection portends a grim prognosis. Efforts to treat these lesions have failed partly because the biologic processes that govern their development are poorly understood. In recent years, it has become evident that metastases occur as a result of a multistep process involving a rigorous natural selection of cells in the primary tumor that bear molecular and biologic characteristics permitting brain metastasis. In addition, recent studies have uncovered the importance of the brain microenvironment and its contribution to the metastatic process. The development of targeted therapies against brain metastases demands a better understanding of these molecular processes and the factors that influence them. This review examines the interplay between tumor cells and host brain tissue in the context of our current understanding of the role of various molecules involved in the metastatic process.
Similar articles
-
Pathobiology of brain metastases.J Clin Pathol. 2005 Mar;58(3):237-42. doi: 10.1136/jcp.2003.013623. J Clin Pathol. 2005. PMID: 15735152 Free PMC article. Review.
-
The biology of metastases in pediatric sarcomas.Cancer J. 2005 Jul-Aug;11(4):306-13. doi: 10.1097/00130404-200507000-00006. Cancer J. 2005. PMID: 16197720 Review.
-
Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.Anticancer Res. 2016 Feb;36(2):523-32. Anticancer Res. 2016. PMID: 26851006
-
Biology of liver metastases.Cancer Treat Res. 2001;109:183-206. doi: 10.1007/978-1-4757-3371-6_10. Cancer Treat Res. 2001. PMID: 11775436 Review.
-
Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention.Cancer Genomics Proteomics. 2016 Jul-Aug;13(4):245-58. Cancer Genomics Proteomics. 2016. PMID: 27365375 Review.
Cited by
-
Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.Cancer Cell Int. 2013 Feb 1;13(1):5. doi: 10.1186/1475-2867-13-5. Cancer Cell Int. 2013. PMID: 23374226 Free PMC article.
-
Neoplastic meningitis: a unique disease process or a 'test tube' for evaluating cancer treatments?Curr Oncol Rep. 2003 Jan;5(1):11-4. doi: 10.1007/s11912-003-0081-z. Curr Oncol Rep. 2003. PMID: 12493145 Review.
-
Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.J Cancer Res Clin Oncol. 2005 Mar;131(3):191-8. doi: 10.1007/s00432-004-0629-9. Epub 2004 Dec 8. J Cancer Res Clin Oncol. 2005. PMID: 15592684 Free PMC article.
-
Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.Oncogene. 2013 Aug 29;32(35):4064-77. doi: 10.1038/onc.2012.417. Epub 2012 Sep 24. Oncogene. 2013. PMID: 23001042 Free PMC article.
-
Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.Am J Pathol. 2010 Jun;176(6):2958-71. doi: 10.2353/ajpath.2010.090838. Epub 2010 Apr 9. Am J Pathol. 2010. PMID: 20382702 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical